NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) – From Nutraceuticals to Cannabinoid Pharmaceuticals

  • Patented nutraceuticals with retail distribution and consumer branding expertise
  • MOU with cannabinoid pharma for research on NeutriSci products for new therapeutics
  • Targeting forefront of new and innovative cannabinoid-based medical products in Canada

In business for nearly a decade, NeutriSci International Inc. (TSX.V: NU) (OTCQB: NRXCF) (FRA: 1N9) has become an established leader in the Canadian nutraceutical markets and continues to develop new sales channels throughout the U.S., Europe and Asia. The company is not only expanding its existing national retail footprint in Canada; it just entered into a major R&D Memorandum of Understanding with Scientus Pharma Inc. to develop, produce and distribute medical cannabinoid products for existing retail distribution networks across Canada.

With a history of specializing in the original formulation and production of products full of health-giving additives and clinically proven medicinal benefit, NeutriSci is recognized for product safety, quality and efficacy. Its sugar free Neuenergy® is a clinically proven, great tasting chewable tablet that provides a quick boost of energy and sharpens focus. Each tablet contains the equivalent anti-oxidants of 25,000 fresh blueberries. These anti-oxidants have a high level of…


More from CannabisNewsWire

About CannabisNewsWire

CannabisNewsWire (CNW) is an information service that provides (1) access to our news aggregation and syndication servers, (2) CannabisNewsBreaks that summarize corporate news and information, (3) enhanced press release services, (4) social media distribution and optimization services, and (5) a full array of corporate communication solutions. As a multifaceted financial news and content distribution company with an extensive team of contributing journalists and writers, CNW is uniquely positioned to best serve private and public companies that desire to reach a wide audience of investors, consumers, journalists and the general public. CNW has an ever-growing distribution network of more than 5,000 key syndication outlets across the country. By cutting through the overload of information in today’s market, CNW brings its clients unparalleled visibility, recognition and brand awareness. CNW is where news, content and information converge.

For more information please visit

Please see full terms of use and disclaimers on the CannabisNewsWire website applicable to all content provided by CNW, wherever published or re-published:

CannabisNewsWire (CNW)
Denver, Colorado
303.498.7722 Office

Leave a Reply